Source: centralcharts

Press Release: Miromatrix : Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop

EDEN PRAIRIE, Minn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Jeff Ross's photo - CEO of Miromatrix

CEO

Jeff Ross

CEO Approval Rating

90/100

Read more